Table 3. Baseline characteristics of 64 male patients with a SVR and 6 without.
| SVR (n = 64) | Non-SVR (n = 6) | P value | |
|---|---|---|---|
| Age (years) | 67 (57–73) | 70 (67–82) | 0.210 |
| Body mass index (kg/m2) | 22.3 (20.8–24.5) | 21.0 (20.0–22.0) | 0.332 |
| Treatment regimen | 0.884 | ||
| Daclatasvir + asunaprevir | 23 | 3 | |
| Ledipasvir + sofosbuvir | 23 | 2 | |
| Sofosbuvir + ribavirin | 18 | 1 | |
| Genotype (1/2) | 46/18 | 5/1 | 0.546 |
| HCV RNA (logIU/mL) | 6.1 (5.8–6.7) | 6.0 (5.2–6.5) | 0.417 |
| Alanine aminotransferase (U/L) | 44 (27–71) | 31 (26–48) | 0.260 |
| Creatinine (mg/dL) | 0.85 (0.79–0.97) | 0.64 (0.64–0.99) | 0.416 |
| Albumin (g/dL) | 4.2 (3.9–4.4) | 4.0 (3.9–4.1) | 0.554 |
| Hemoglobin (g/dL) | 15.2 (13.7–15.7) | 12.3 (12.0–12.5) | 0.067 |
| Platelets (×104/mm3) | 14.7 (10.9–19.6) | 8.2 (6.3–10.0) | 0.093 |
| α-fetoprotein (ng/mL) | 4.5 (2.4–9.2) | 6.3 (4.7–10.8) | 0.444 |
| FIB-4 index | 3.06 (2.01–4.66) | 4.43 (3.91–4.93) | 0.288 |
| APRI | 1.10 (0.77–2.06) | 1.35 (0.80–1.76) | 0.976 |
| Autotaxin (mg/L) | 1.33 (0.97–1.60) | 1.35 (0.88–1.69) | 0.976 |
Values are expressed as the median (interquartile range).